← All indications
Ear Diseases
Pathological processes of the ear, the hearing, and the equilibrium system of the body.
Subtype terms (16)
More specific conditions that are subtypes of Ear Diseases in the MeSH hierarchy.
- Cholesteatoma, Middle Ear
- Congenital Microtia
12 drugs (3 approved, 9 experimental)
- Earache
1 drug approved
- Ear Deformities, Acquired
1 drug approved
- Ear Neoplasms
1 drug experimental
- Hearing Disorders
8 drugs (4 approved, 4 experimental)
- Herpes Zoster Oticus
- Labyrinth Diseases
2 drugs (1 approved, 1 experimental)
- Otitis
18 drugs (12 approved, 6 experimental)
- Otomycosis
9 drugs (4 approved, 5 experimental)
- Otosclerosis
4 drugs approved
- Ototoxicity
15 drugs (10 approved, 5 experimental)
- Retrocochlear Diseases
- Susac Syndrome
- Tympanic Membrane Perforation
12 drugs (5 approved, 7 experimental)
- Tympanosclerosis
Drugs by status
Phase 2 trials (5)
Organizations
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (15)
- Swedish Orphan Biovitrum
- Nordmark Arzneimittel GmbH & Co. KG
- Otic Pharma
- Xoma
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- House Research Institute
- Northwell Health
- Tel Aviv University
- Feinstein Institute for Medical Research
- LCR Clinical Research
- Janssen Pharmaceutica NV
- ClinSupport GmbH
- MWI Medizinisches Wirtschaftsinstitut GmbH
- ProjectPharm s.r.o.
- X-act Cologne Clinical Research GmbH
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (1)